Abstract
PREVIEWThe evaluation and management of acute coronary syndrome are undergoing rapid development and change in the United States in an attempt to better define patient risk and guide triage decisions. Here, Dr Rosamond explores the current theories about what pathobiologic factors take part in acute coronary syndrome. He also details the strategies and technology, both available and under development, that can help direct accurate diagnosis and identify patient risk.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
